European Journal of Nutrition

, Volume 47, Issue 5, pp 235–243

The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis

  • Lihui Wang
  • Chengyan Geng
  • Liping Jiang
  • Dezheng Gong
  • Dayu Liu
  • Hiroyuki Yoshimura
  • Laifu Zhong



The anti-atherogenic effect of olive leaf extract is supposed to be related to its activities of anti-oxidation and anti-inflammation.

Aim of the study

To prove the effect of anti-atherosclerosis by olive leaf extract (OLE) and to elucidate the mechanism behind.


Twenty-four rabbits were assigned to the control, high lipid diet (HLD) and OLE group that were fed with standard diet, HLD and HLD supplemented with OLE, respectively. Serum levels of atherosclerosis related markers, triglyceride (TG), total cholesterol (T-CHO), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and malondialdehyde (MDA) were detected at the ends of week 2, 4 and 6. Surface lesions and thickness of intimas were measured at the end of week6. The protein and/or mRNA expressions of inflammation factors, monocyte chemoattractant protein (MCP)-1, vascular cell adhesion molecule (VCAM)-1, nuclear factor-kappa B (NF-κB) and tumor necrosis factor α (TNF-α) were investigated by immunohistochemistry and RT-PCR.


Atherosclerotic lesions were found in the HLD and OLE groups but not in the control group. In comparison with that in the HLD group, reduced size and thickness of intima (0.31 ± 0.26 in the HLD group versus 0.10 ± 0.03 mm in the OLE group) were found in the OLE group. The MDA level, an indicator of antioxidant status, was 35.27 ± 15.37 in the HLD group and 20.63 ± 11.52 nmol/ml in the OLE group. The level of CHO, TG and LDL-C were 104.46 ± 30.34, 2.48 ± 1.11, 82.83 ± 28.44 mmol/l in the HLD group versus 83.03 ± 27.23, 1.84 ± 0.44, 59.51 ± 23.72 mmol/l in the OLE group. Down-regulated expressions of MCP-1, VCAM-1, NF-κB and TNF-α at both protein and mRNA level (P < 0.05) were also found with the administration of OLE.


This study proved the effect of OLE on inhibition of atherosclerosis, which is related to the suppressed inflammatory response.


altherosclerosis olive leaf extract inflammatory response inflammatory factor 


  1. 1.
    Aguilera CM, Ramirez-Tortosa MC, Mesa MD, Ramirez-Tortosa CL, Gil A (2002) Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162:335–344CrossRefGoogle Scholar
  2. 2.
    Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170:191–203CrossRefGoogle Scholar
  3. 3.
    Bogani P, Galli C, Villa M, Visioli F (2007) Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 190:181–186CrossRefGoogle Scholar
  4. 4.
    Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion J Clin Invest 97:1715–1722CrossRefGoogle Scholar
  5. 5.
    Breslow JL (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3:600–601CrossRefGoogle Scholar
  6. 6.
    Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844Google Scholar
  7. 7.
    Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622–629CrossRefGoogle Scholar
  8. 8.
    Collins T, Cybulsky MI (2001) NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255–264CrossRefGoogle Scholar
  9. 9.
    Covas MI, de la Torre K, Farre-Albaladejo M, Kaikkonen J, Fito M, Lopez-Sabater C, Pujadas-Bastardes MA, Joglar J, Weinbrenner T, Lamuela-Raventos RM, de la Torre R (2006) Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med 40:608–616CrossRefGoogle Scholar
  10. 10.
    Cullinen K (2006) Olive oil in the treatment of hypercholesterolemia. Med Health R I 89:113Google Scholar
  11. 11.
    Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107:1255–1262CrossRefGoogle Scholar
  12. 12.
    Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI, Smith JD (2001) Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 21:1662–1667CrossRefGoogle Scholar
  13. 13.
    Dayu L, Xiaomian Z, Runtao Z, Nannan Y, Guohui C, Wei X, Xiaodan M, Bingcheng L (2006) Analysis of multiplex PCR fragments with PMMA microchip. Talanta 68:616–622CrossRefGoogle Scholar
  14. 14.
    de la Puerta R, Martinez Dominguez ME, Ruiz-Gutierrez V, Flavill JA, Hoult JR (2001) Effects of virgin olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic neurotransmission. Life Sci 69:1213–1222CrossRefGoogle Scholar
  15. 15.
    de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E (2003) Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107:690–695CrossRefGoogle Scholar
  16. 16.
    de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation 99:779–785Google Scholar
  17. 17.
    Dell’agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E (2007) Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br J Nutr 99:945–951Google Scholar
  18. 18.
    Fruebis J, Gonzalez V, Silvestre M, Palinski W (1997) Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol 17:1289–1302Google Scholar
  19. 19.
    Gimbrone MA Jr, Cybulsky MI, Kume N, Collins T, Resnick N (1995) Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci 748:122–131; discussion 131–122CrossRefGoogle Scholar
  20. 20.
    Gonzalez-Santiago M, Martin-Bautista E, Carrero JJ, Fonolla J, Baro L, Bartolome MV, Gil-Loyzaga P, Lopez-Huertas E (2006) One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 188:35–42CrossRefGoogle Scholar
  21. 21.
    Harrington JR (2000) The role of MCP-1 in atherosclerosis. Stem Cells 18:65–66CrossRefGoogle Scholar
  22. 22.
    Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK 3rd, Roux-Lombard P, Burger D (2001) Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381–2389CrossRefGoogle Scholar
  23. 23.
    Khan BV, Parthasarathy SS, Alexander RW, Medford RM (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95:1262–1270CrossRefGoogle Scholar
  24. 24.
    Kumar A, Middleton A, Chambers TC, Mehta KD (1998) Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1beta- and tumor necrosis factor-alpha- induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 273:15742–15748CrossRefGoogle Scholar
  25. 25.
    Li M, Zhang Y, Ren H, Zhang Y, Zhu X (2007) Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 194:348–356CrossRefGoogle Scholar
  26. 26.
    Maiuri MC, De Stefano D, Di Meglio P, Irace C, Savarese M, Sacchi R, Cinelli MP, Carnuccio R (2005) Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn Schmiedebergs Arch Pharmacol 371:457–465CrossRefGoogle Scholar
  27. 27.
    Martinez-Dominguez E, de la Puerta R, Ruiz-Gutierrez V (2001) Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet. Inflamm Res 50:102–106CrossRefGoogle Scholar
  28. 28.
    Matsubara M, Hasegawa K (2004) Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells. Eur J Pharmacol 498:303–314CrossRefGoogle Scholar
  29. 29.
    Perez-Martinez P, Lopez-Miranda J, Blanco-Colio L, Bellido C, Jimenez Y, Moreno JA, Delgado-Lista J, Egido J, Perez-Jimenez F (2007) The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in peripheral blood mononuclear cells from healthy men. Atherosclerosis 194:e141–e146CrossRefGoogle Scholar
  30. 30.
    Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126CrossRefGoogle Scholar
  31. 31.
    Rogers KA, Hoover RL, Castellott JJJ, Robinson JM, Karnovsky MJ (1986) Dietary cholesterol-induced changed in macrophage characteristics relationship to atherosclerosis. Am J Pathol 125:284–291Google Scholar
  32. 32.
    Shibata Y, Kume N, Arai H, Hayashida K, Inui-Hayashida A, Minami M, Mukai E, Toyohara M, Harauma A, Murayama T, Kita T, Hara S, Kamei K, Yokode M (2007) Mulberry leaf aqueous fractions inhibit TNF-alpha-induced nuclear factor kappaB (NF-kappaB) activation and lectin-like oxidized LDL receptor-1 (LOX-1) expression in vascular endothelial cells. Atherosclerosis 193:20–27CrossRefGoogle Scholar
  33. 33.
    Thurberg BL, Collins T (1998) The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 9:387–396CrossRefGoogle Scholar
  34. 34.
    Tipping PG, Hancock WW (1993) Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 142:1721–1728Google Scholar
  35. 35.
    Visioli F, Bellomo G, Galli C (1998) Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 247:60–64CrossRefGoogle Scholar
  36. 36.
    Visioli F, Galli C, Plasmati E, Viappiani S, Hernandez A, Colombo C, Sala A (2000) Olive phenol hydroxytyrosol prevents passive smoking-induced oxidative stress. Circulation 102:2169–2171Google Scholar
  37. 37.
    Wang JY, Wen LL, Huang YN, Chen YT, Ku MC (2006) Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12:3521–3533CrossRefGoogle Scholar
  38. 38.
    Zheng S, Qian Z, Sheng L, Wen N (2006) Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation. J Cardiovasc Pharmacol 47:70–76CrossRefGoogle Scholar

Copyright information

© Spinger 2008

Authors and Affiliations

  • Lihui Wang
    • 1
  • Chengyan Geng
    • 2
  • Liping Jiang
    • 2
  • Dezheng Gong
    • 2
  • Dayu Liu
    • 3
  • Hiroyuki Yoshimura
    • 4
  • Laifu Zhong
    • 2
  1. 1.Dept. of PathologyDalian Medical UniversityDalianChina
  2. 2.China-Japanese Joint Institute for Medical and Pharmaceutical ScienceDalian Medical UniversityDailanChina
  3. 3.Biomedical Engineering CenterImprove Medical Instrument’s Co. Ltd.GuangzhouChina
  4. 4.Eisai Food and Chemical Co., LtdTokyoJapan

Personalised recommendations